Cargando…

Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic

INTRODUCTION Besides many problematics the Covid-19 pandemic has triggered, one issue remains the care of chronically ill patients. Regarding sickle cell disease (SCD), patients often present co-morbidities that could predispose them to poor outcome if they get infected. Vaso-occlusive crisis (VOC),...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Luna, Gonzalo, Lemonier, Nicolas, Aidan, Alexis, Bontemps, Lea, Hautefaye, Manuel, Diakonoff, Hadrien, Aubrun, Cecile, Pham Hung D'Alexandry D'Orengiani, Anne-Laure, Bachir, Dora, Driss, Françoise, Jebali, Amna, Habibi, Anoosha, Bartolucci, Pablo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology. Published by Elsevier Inc. 2020
Materias:	113.Hemoglobinopathies, Excluding Thalassemia-New Genetic Approaches to Sickle Cell Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330336/ http://dx.doi.org/10.1182/blood-2020-142796

Ejemplares similares

Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic
por: Pelinski, Yanís, et al.
Publicado: (2021)

Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease
por: Tarasev, Michael, et al.
Publicado: (2021)

Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report
por: Alghamdi, Badria M., et al.
Publicado: (2020)

Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease
por: Anusim, Nwabundo, et al.
Publicado: (2020)

Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic
por: Nowlin, Andrea, et al.
Publicado: (2020)

Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience
por: Sewaralthahab, Sarah, et al.
Publicado: (2020)

Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS)
por: Lam, Ho Pui Jeff, et al.
Publicado: (2020)

Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection
por: Merz, Lauren E., et al.
Publicado: (2020)

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic
por: Davila, Jennifer G., et al.
Publicado: (2020)

Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection
por: Mucalo, Lana, et al.
Publicado: (2020)

Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease
por: Abdelaal, Mahmoud A.Z., et al.
Publicado: (2020)

Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina
por: Noisette, Laurence, et al.
Publicado: (2020)

Identification of the Pitfalls in the Attempted Use of Extracorporeal Membrane Oxygenation in an Adult Patient with Sickle Cell Disease and Severe Acute Chest Syndrome
por: Tanenbaum, Mira T, et al.
Publicado: (2019)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center
por: El Rassi, Fuad, et al.
Publicado: (2021)

COVID-19 in Hospitalized Patients with Sickle Cell Disease
por: Guarino, Stephanie, et al.
Publicado: (2021)

Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study
por: Konté, Kadère, et al.
Publicado: (2021)

Excess All-Cause Mortality in 2020 for People Living with Sickle Cell Disease in New York City
por: Curtis, Susanna A, et al.
Publicado: (2021)

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience
por: Devarashetty, Sindhu, et al.
Publicado: (2021)

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
por: Rao, Shivani, et al.
Publicado: (2021)

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
por: Rao, Shivani, et al.
Publicado: (2021)

Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease
por: Orkoulas-Razis, Dennis, et al.
Publicado: (2021)

Results of Operative and Nonoperative Treatment of Rockwood Types III and V Acromioclavicular Joint Dislocation: A Prospective, Randomized Trial With an 18- to 20-Year Follow-up
por: Joukainen, Antti, et al.
Publicado: (2014)

Characterisation of different forms of the accessory gp3 canine coronavirus type I protein identified in cats
por: Pham-Hung d’Alexandry d’Orengiani, Anne-Laure, et al.
Publicado: (2015)

Sickle Cell Disease in Africa: A Neglected Cause of Early Childhood Mortality
por: Grosse, Scott D., et al.
Publicado: (2011)

Psychometric characteristics of the Revised Illness Perception Questionnaire (IPQ-R) in adults with sickle cell disease
por: Oudin Doglioni, Damien, et al.
Publicado: (2021)

Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry
por: Lee, Jihye, et al.
Publicado: (2017)

Thromboprophylaxis Reduced Venous Thromboembolism in Sickle Cell Patients with Central Venous Access Devices: A Retrospective Cohort Study
por: Forté, Stéphanie, et al.
Publicado: (2022)

Variation and impact of polygenic hematologic traits in monogenic sickle cell disease
por: Pincez, Thomas, et al.
Publicado: (2022)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

PB2505: THERAPEUTIC PHLEBOTOMY INSTANTLY AFFECTS BLOOD PARAMETERS AND VISCOCITY IN SICKLE CELL DISEASE PATIENTS
por: Jebali, Amna, et al.
Publicado: (2023)

Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19
por: Ko, Meehyun, et al.
Publicado: (2021)

P1438: L-GLUTAMINE: A NOVEL AND EFFECTIVE THERAPEUTIC TOOL FOR VOC REDUCTION IN SCD
por: Zaouali, Yosr, et al.
Publicado: (2023)

When to start: not so fast
por: Lundgren, J
Publicado: (2012)

Peripartum Outcomes Following COVID-19 Vaccination in Late Pregnancy: Findings from a Population-Based Retrospective Cohort Study in Ontario, Canada
por: El-Chaâr, Darine, et al.
Publicado: (2022)

Are reentrant atrial tachycardias sensitive to adenosine administration?
por: Guido Lopez, L E, et al.
Publicado: (2023)

Spontaneous variation of ventriculoatrial interval after tachycardia induction: determinants and usefulness in the diagnosis of supraventricular tachycardias with long ventriculoatrial interval
por: Duran-Bobin, O, et al.
Publicado: (2023)

Identification of cavotricuspid isthmus conduction block, pitfall of differential pacing maneuver
por: Park, S, et al.
Publicado: (2023)

Non-invasive electrocardiographic imaging for the characterization of complex atrial tachyarrhythmias
por: Reventos-Presmanes, J, et al.
Publicado: (2023)

The effects of catheter choice on accessory pathway mapping efficiency
por: Mariucci, E M, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_44aqqhdttbd6tn96gu8554l7og